Form D · Biotechnology

Frequency Therapeutics, Inc.

Woburn, MA · CIK 0001703647

Offering snapshot reported Jul 27, 2020 · SEC filing

Reported sold
$42.3M
Offering amount: $42.3M
Investors reported
18
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jul 20, 2020
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 27, 2020Initial$42,301,944No comparison18SEC filing
Jul 23, 2019Initial$61,999,366No comparison80SEC filing
Apr 14, 2017Initial$32,000,000No comparison90SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$2.05M
Finders' fees
$0
Form D file number
021-371826

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Cowen and Company, LLC7616

Source: Form D, filed Jul 27, 2020. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Wendy S. Arnold Executive
Timothy J. Barberich Director
Marc A. Cohen Director
Dana Hilt Executive
Michael Huang Director
Marc Kozin Director
Robert S. Langer Director
Carl Lebel Executive
Carl P. Le Bel Executive
Christopher R. Loose Executive
David L. Lucchino Director, Executive
Joel S. Marcus Director
Richard Mitrano Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
19 Presidential Way, Suite 203
Woburn, MA, 01801